Synthetic T and B cell recognition sites: implications for vaccine development - PubMed (original) (raw)
Review
Synthetic T and B cell recognition sites: implications for vaccine development
D R Milich. Adv Immunol. 1989.
No abstract available
Similar articles
- Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopes.
Tam JP, Lu YA. Tam JP, et al. Proc Natl Acad Sci U S A. 1989 Dec;86(23):9084-8. doi: 10.1073/pnas.86.23.9084. Proc Natl Acad Sci U S A. 1989. PMID: 2480595 Free PMC article. - Polyvalent synthetic vaccines: relationship between T epitopes and immunogenicity.
Jolivet M, Lise L, Gras-Masse H, Tartar A, Audibert F, Chedid L. Jolivet M, et al. Vaccine. 1990 Feb;8(1):35-40. doi: 10.1016/0264-410x(90)90175-l. Vaccine. 1990. PMID: 1690488 - Synthetic peptides: prospects for vaccine development.
Milich DR. Milich DR. Semin Immunol. 1990 Sep;2(5):307-15. Semin Immunol. 1990. PMID: 2134015 Review. - Plasmodium berghei subunit vaccine: repeat synthetic peptide of circumsporozoite protein comprising T- and B-cell epitopes fails to confer immunity.
Migliorini P, Boulanger N, Betschart B, Corradin G. Migliorini P, et al. Scand J Immunol. 1990 Feb;31(2):237-42. doi: 10.1111/j.1365-3083.1990.tb02764.x. Scand J Immunol. 1990. PMID: 1689867 - Modelling determinants for recognition by B cells and T cells.
Goodman JW. Goodman JW. Chem Immunol. 1989;46:1-22. doi: 10.1159/000318820. Chem Immunol. 1989. PMID: 2482035 Review. No abstract available.
Cited by
- Computational prediction of multiple antigen epitopes.
Viswanathan R, Carroll M, Roffe A, Fajardo JE, Fiser A. Viswanathan R, et al. Bioinformatics. 2024 Oct 1;40(10):btae556. doi: 10.1093/bioinformatics/btae556. Bioinformatics. 2024. PMID: 39271143 Free PMC article. - B-Cell Epitope Predictions Using Computational Methods.
Zheng D, Liang S, Zhang C. Zheng D, et al. Methods Mol Biol. 2023;2552:239-254. doi: 10.1007/978-1-0716-2609-2_12. Methods Mol Biol. 2023. PMID: 36346595 - TLR Agonist Augments Prophylactic Potential of Acid Inducible Antigen Rv3203 against Mycobacterium tuberculosis H37Rv in Experimental Animals.
Mohammad O, Kaur J, Singh G, Faisal SM, Azhar A, Rauf MA, Gupta UD, Gupta P, Pal R, Zubair S. Mohammad O, et al. PLoS One. 2016 Mar 29;11(3):e0152240. doi: 10.1371/journal.pone.0152240. eCollection 2016. PLoS One. 2016. PMID: 27023750 Free PMC article. - Immunization with a novel chimeric peptide representing B and T cell epitopes from HER2 extracellular domain (HER2 ECD) for breast cancer.
Mahdavi M, Keyhanfar M, Jafarian A, Mohabatkar H, Rabbani M. Mahdavi M, et al. Tumour Biol. 2014 Dec;35(12):12049-57. doi: 10.1007/s13277-014-2503-y. Epub 2014 Aug 21. Tumour Biol. 2014. PMID: 25142233 - SVMTriP: a method to predict antigenic epitopes using support vector machine to integrate tri-peptide similarity and propensity.
Yao B, Zhang L, Liang S, Zhang C. Yao B, et al. PLoS One. 2012;7(9):e45152. doi: 10.1371/journal.pone.0045152. Epub 2012 Sep 12. PLoS One. 2012. PMID: 22984622 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical